Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

NCT04408794 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
974
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer